Safer dialysis for bleeding risk patients: study tests local vs. Whole-Body blood thinners
NCT ID NCT03562754
Summary
This study tested two different ways to prevent blood clotting during dialysis for patients in intensive care who are at high risk of bleeding. It compared a method that thins blood only in the dialysis machine (regional citrate) to a low-dose method that thins blood throughout the whole body (heparin). The goal was to see which method is safer and more effective for these vulnerable patients.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HEMODIALYSIS are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
CHU Nimes
Nîmes, 30029, France
Conditions
Explore the condition pages connected to this study.